DA
Therapeutic Areas
Artivion Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AMDS Hybrid Prosthesis | Acute DeBakey Type I Aortic Dissection with Malperfusion | Pivotal (HDE Approved) |
| On-X Aortic Heart Valve | Real-world outcomes with Low Dose Anticoagulation | Post-Market Study |
Leadership Team at Artivion
JP
J. Patrick Mackin
Chairman, President & CEO
JF
Jean F. Holloway
VP, General Counsel & Corporate Secretary
JP
John P. (Pat) Hussey
VP, Global Operations
LL
Lindsay L. Weber
VP, Human Resources
TJ
Todd J. Sheeran
VP, Global Sales
SL
S. Lance Bussang
VP, Corporate Development & Strategy
JW
James W. Bullock
VP, Global Marketing & Education
MR
Matthew R. Stultz
VP, Global Clinical & Regulatory Affairs
JJ
John J. Arlotta
Lead Independent Director
MK
M. Kathleen Behrens
Director